ALK Gene Rearrangement and PD-L1 Expression

Video Library - Lung Cancer
Edward Garon, MD
Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement.
Related Items
Smoking Cessation and Lung Cancer
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Screening for Lung Cancer
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Who Should be Screened for Lung Cancer?
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Common Presenting Factors for NSCLC
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Shifts in Lung Cancer Treatment
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
A Look at PD-1 and PD-L1 Inhibitors
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Differences in NSCLC Patient Populations
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Choosing the Right Therapy for Patients with NSCLC
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Immunotherapies and Lung Cancer
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
My Practice: Roles and Responsibilities
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Last modified: April 27, 2017